Information Provided By: 
Fly News Breaks for July 22, 2019
MBOT
Jul 22, 2019 | 07:07 EDT
H.C. Wainwright analyst Raghuram Selvaraju started Microbot Medical with a Buy rating and $10 price target. Microbot is an "emerging pioneer" in the field of surgical micro-robotics, and its lead technology platform, a self-cleaning shunt, could prove a key disruptor in the field of shunt devices, Selvaraju tells investors in a research note.
News For MBOT From the Last 2 Days
There are no results for your query MBOT
